Proton Pump Inhibitors Linked to Chronic Kidney Disease
While study can't prove cause-and-effect, increasing damage seen as dose rises
U.S. Cancer Mortality Rates Down 23 Percent Since 1991
That translates to an additional 1.7 million survivors
ASCO: Cabozantinib Improves Progression-Free Survival in RCC
Improvements seen across patient subgroups defined by risk category, tumor burden, prior therapy
Many Patients Using E-Mail As First Method of Provider Contact
Online communications reduced need for phone calls and office visits for many
Angiotensin Receptor Blockers, ACEIs Deemed Equally Effective
Research challenges previous findings that suggest ACE inhibitors have greater benefits
December 2015 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for December 2015. This roundup includes the latest...
AMA: Burnout Is Top Issue for Physicians in 2015
More than half of docs report at least one symptom of burnout; efforts being undertaken to address burnout
PSA Screening May Be Harmful for Patients With ESRD
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant
Higher Hospital Prices in U.S. ‘Monopoly Markets’
Hospital prices positively associated with indicators of hospital market power
FDA Approves Zurampic for the Treatment of Gout
Drug helps control blood levels of uric acid
